DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 172 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 2,456,595 | $49,525,000 | 9.00% |
COMMODORE CAPITAL LP | 1,292,251 | $26,052,000 | 6.87% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $62,098,000 | 3.85% |
GREAT POINT PARTNERS LLC | 799,999 | $16,128,000 | 3.76% |
DAFNA Capital Management LLC | 587,456 | $11,843,000 | 3.14% |
Eagle Health Investments LP | 406,525 | $8,196,000 | 2.60% |
RTW INVESTMENTS, LP | 7,582,396 | $152,861,000 | 2.30% |
Parkman Healthcare Partners LLC | 209,686 | $4,227,000 | 1.07% |
Palo Alto Investors LP | 855,713 | $17,251,000 | 1.04% |
Lombard Odier Asset Management (Switzerland) SA | 701,305 | $14,138,000 | 0.88% |